Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.30

ORKAOruka Therapeutics, Inc.

$1B

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$7,000

Operating Income

-$4M

Net Income

-$4M

EPS (Diluted)

$-83.24

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$17M

Total Liabilities

$3M

Stockholders' Equity

$14M

Cash & Equivalents

$8M

← FY 2017 All Quarters Q4 2017 →

ORKA Q3 2017 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena